Novo Nordisk says Wegovy heart benefits due to more than weight loss
Novo Nordisk says Wegovy heart benefits due to more than weight loss
Early trial data demonstrated that Wegovy, which has been shown to help patients lose an average of 15% of their weight, also reduced incidence of heart attack, stroke or death from heart disease by 20%.
You're viewing a single thread.
Full results from the study, presented at the American Heart Association annual scientific meeting in Philadelphia and published in the New England Journal of Medicine, suggest the drug has other beneficial effects beyond the known health benefits from losing weight.
The heart risk difference between patients who received Wegovy, known chemically as semaglutide, and those on placebo began to appear almost immediately after starting treatment, researchers said.
So it’s not just from losing weight!
The associated risk factors include inflammation, blood pressure and blood sugar control, all of which can impact heart health.
Patients on Wegovy experienced decreases in C-reactive proteins, an indication of inflammation, similar to those reported with cholesterol lowering statins, which are known to significantly lower heart risks, researchers reported.
That is really promising!
We know that diabetes is a "heart attack" equivalent. As in if you have diabetes, your risk for heart attack is as if you've already had one, which is to say higher.
ANY control over your weight, diet, and smoking can help reduce the risk. Semaglutide is nothing new, it's been around for two decades now. It's another medication in a long list of medications that can help people with diabetes.
What I'm saying is that, if you need it, you should get it. If you don't need it, don't be lazy, just do the lifestyle stuff.